High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series

<i>Background</i>: The evidence on high-dose ifosfamide (HD-IFO) use in patients with relapsed osteosarcoma is limited. We performed a retrospective study to analyze HD-IFO activity. <i>Methods</i>: Patients with osteosarcoma relapsed after standard treatment [methotrexate, d...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani, Lorenzo D’Ambrosio, Alessandro Comandone, Alberto Righi, Alessandra Longhi, Marilena Cesari, Anna Paioli, Rossella Hakim, Michela Pierini, Emanuela Marchesi, Daniel Vanel, Ymera Pignochino, Davide Maria Donati, Piero Picci, Stefano Ferrari
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2020-10-01
Reeks:Cells
Onderwerpen:
osteosarcoma
high-grade bone sarcoma
pediatric bone tumors
ifosfamide
chemotherapy
PARP1
Online toegang:https://www.mdpi.com/2073-4409/9/11/2389
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items